422 filings
8-K
SLNO
Soleno Therapeutics Inc
9 May 24
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
7:36pm
10-Q
2024 Q1
SLNO
Soleno Therapeutics Inc
Quarterly report
9 May 24
4:31pm
8-K
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
8-K
twa8x8w372981 qn6ru
29 Apr 24
First Ever Breakthrough Designation for a Drug Being Developed for PWS
4:08pm
ARS
d8u btfkjn
22 Apr 24
Annual report to shareholders
5:06pm
8-K
ewilh
22 Apr 24
Departure of Directors or Certain Officers
4:15pm
8-K
kxbcjr0
7 Mar 24
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
6:06am
S-8
9o202k5
31 Jan 24
Registration of securities for employees
4:19pm
8-K
8gc35v8j
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
S-8
aki6npe 3a40vfm
17 Jan 24
Registration of securities for employees
4:06pm
8-K
oc4xx bl7t1m08u
5 Jan 24
Departure of Directors or Certain Officers
4:16pm
S-3ASR
ufrsz1lpdini9tv1hvc7
2 Jan 24
Automatic shelf registration
4:06pm
EFFECT
1rjc3xnglebf6wev qf
1 Nov 23
Notice of effectiveness
12:15am
CORRESP
z22zuoax
27 Oct 23
Correspondence with SEC
12:00am
UPLOAD
ui0ds7w
27 Oct 23
Letter from SEC
12:00am